
|Videos|May 3, 2013
Access to Innovation
In this video, executives from AstraZeneca and MedImmune explain why access to innovation in the development of biologics is so important.
Advertisement
In this video shot at BIO International Convention 2013, executives from AstraZeneca and MedImmune explain why access to innovation in the development of biologics is so important.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury
3
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
4
Balancing Survival and Quality of Life in Pancreatic Cancer: Expert Perspectives From an Immuneering Panel
5


























